Intramyocellular lipid accumulation and reduced whole body lipid oxidation in HIV lipodystrophy

Divisions of 4  Infectious Diseases, 5  Diagnostic Radiology, and 6  Nuclear Medicine, 2  Clinical Research Unit II, and 3  Clinical Spectroscopy Unit, San Raffaele Scientific Institute, and 1  International Center for Assessment of the Nutritional Status, Universita' degli Studi di Milano, 201...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of physiology: endocrinology and metabolism 2003-02, Vol.284 (2), p.E274-E280
Hauptverfasser: Luzi, Livio, Perseghin, Gianluca, Tambussi, Giuseppe, Meneghini, Elena, Scifo, Paola, Pagliato, Emanuela, Del Maschio, Alessandro, Testolin, Giulio, Lazzarin, Adriano
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page E280
container_issue 2
container_start_page E274
container_title American journal of physiology: endocrinology and metabolism
container_volume 284
creator Luzi, Livio
Perseghin, Gianluca
Tambussi, Giuseppe
Meneghini, Elena
Scifo, Paola
Pagliato, Emanuela
Del Maschio, Alessandro
Testolin, Giulio
Lazzarin, Adriano
description Divisions of 4  Infectious Diseases, 5  Diagnostic Radiology, and 6  Nuclear Medicine, 2  Clinical Research Unit II, and 3  Clinical Spectroscopy Unit, San Raffaele Scientific Institute, and 1  International Center for Assessment of the Nutritional Status, Universita' degli Studi di Milano, 20132 Milan, Italy Antiretroviral therapy in human immunodeficiency virus (HIV)-positive patients can induce a lipodystrophy syndrome of peripheral fat wasting and central adiposity, dyslipidemia, and insulin resistance. To test whether in this syndrome insulin resistance is associated with abnormal muscle handling of fatty acids, 12 HIV-1 patients (8 females/4 males , age = 26 ± 2 yr, HIV duratio n  = 8 ± 1 yr, body mass index = 22.0 ± 1.0 kg/m 2 , on protease inhibitors and nucleoside analog RT inhibitors) and 12 healthy subjects were studied. HIV-1 patients had a total body fat content (assessed by dual-energy X-ray absorptiometry) similar to that of controls (22 ± 1 vs. 23 ± 2%; P  = 0.56), with a topographic fat redistribution characterized by reduced fat content in the legs (18 ± 2 vs. 32 ± 3%; P  
doi_str_mv 10.1152/ajpendo.00391.2001
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_18760741</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>18760741</sourcerecordid><originalsourceid>FETCH-LOGICAL-c418t-27b30f485a6da1c62a0489f51446621e08f984dc09e2d252786371a3fca1c4803</originalsourceid><addsrcrecordid>eNqFkMFu3CAURVHVqpmm_YEuKq-68wQe2MCyipJmpEjZpN0iBnCGCBsXbCX--zAdR1lVXSF45149DkJfCd4S0sCFfhzdYOMWYyrJFjAm79CmDKAmTdO8RxtMJK2JYPIMfcr5EWPMGwYf0RkBKgShcoPUbpiS7pdoXAhz0KkKfvS20sbMfblPPg6VHmyVnJ2Ns9XTIQZX7aNdVjI-e3vC_FDd7H4fn8s0TymOh-Uz-tDpkN2X9TxHv66v7i9v6tu7n7vLH7e1YURMNfA9xR0TjW6tJqYFjZmQXUMYa1sgDotOCmYNlg4sNMBFSznRtDOFZgLTc_T91Dum-Gd2eVK9z8c_6cHFOSsOkgMw_l-QCN5izkgB4QSaFHNOrlNj8r1OiyJYHf2r1b_6618d_ZfQt7V93vfOvkVW4QWQJ-DgHw5PPjlVJGUfQ3xY1PUcwr17nl6bQTAF6go4U6PtSrb-d_Z1mbcMfQG64ag6</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>18760741</pqid></control><display><type>article</type><title>Intramyocellular lipid accumulation and reduced whole body lipid oxidation in HIV lipodystrophy</title><source>MEDLINE</source><source>American Physiological Society</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Luzi, Livio ; Perseghin, Gianluca ; Tambussi, Giuseppe ; Meneghini, Elena ; Scifo, Paola ; Pagliato, Emanuela ; Del Maschio, Alessandro ; Testolin, Giulio ; Lazzarin, Adriano</creator><creatorcontrib>Luzi, Livio ; Perseghin, Gianluca ; Tambussi, Giuseppe ; Meneghini, Elena ; Scifo, Paola ; Pagliato, Emanuela ; Del Maschio, Alessandro ; Testolin, Giulio ; Lazzarin, Adriano</creatorcontrib><description>Divisions of 4  Infectious Diseases, 5  Diagnostic Radiology, and 6  Nuclear Medicine, 2  Clinical Research Unit II, and 3  Clinical Spectroscopy Unit, San Raffaele Scientific Institute, and 1  International Center for Assessment of the Nutritional Status, Universita' degli Studi di Milano, 20132 Milan, Italy Antiretroviral therapy in human immunodeficiency virus (HIV)-positive patients can induce a lipodystrophy syndrome of peripheral fat wasting and central adiposity, dyslipidemia, and insulin resistance. To test whether in this syndrome insulin resistance is associated with abnormal muscle handling of fatty acids, 12 HIV-1 patients (8 females/4 males , age = 26 ± 2 yr, HIV duratio n  = 8 ± 1 yr, body mass index = 22.0 ± 1.0 kg/m 2 , on protease inhibitors and nucleoside analog RT inhibitors) and 12 healthy subjects were studied. HIV-1 patients had a total body fat content (assessed by dual-energy X-ray absorptiometry) similar to that of controls (22 ± 1 vs. 23 ± 2%; P  = 0.56), with a topographic fat redistribution characterized by reduced fat content in the legs (18 ± 2 vs. 32 ± 3%; P  &lt; 0.01) and increased fat content in the trunk (25 ± 2 vs. 19 ± 2%; P  = 0.03). In HIV-positive patients, insulin sensitivity (assessed by QUICKI) was markedly impaired (0.341 ± 0.011 vs. 0.376 ± 0.007; P  = 0.012). HIV-positive patients also had increased total plasma cholesterol (216 ± 20   vs. 174 ± 9 mg/dl; P  = 0.05) and triglyceride (298 ± 96 vs. 87   ± 11 mg/dl; P  = 0.03) concentrations. Muscular triglyceride content assessed by means of 1 H NMR spectroscopy was higher in HIV patients in soleus [92 ±   12 vs. 42 ± 5 arbitrary units (AU); P  &lt; 0.01] and tibialis anterior (26 ± 6 vs. 11 ± 3 AU; P  = 0.04) muscles; in a stepwise regression analysis, it was strongly associated with QUICKI ( R 2  = 0.27; P  &lt; 0.0093). Even if the basal metabolic rate (assessed by indirect calorimetry) was comparable to that of normal subjects, postabsorptive lipid oxidation was significantly impaired (0.30   ± 0.07 vs. 0.88 ± 0.09 mg · kg 1 · min 1 ; P  &lt; 0.01). In conclusion, lipodystrophy in HIV-1 patients in antiretroviral treatment is associated with intramuscular fat accumulation, which may mediate the development of the insulin resistance syndrome. human immunodeficiency virus</description><identifier>ISSN: 0193-1849</identifier><identifier>EISSN: 1522-1555</identifier><identifier>DOI: 10.1152/ajpendo.00391.2001</identifier><identifier>PMID: 12388139</identifier><language>eng</language><publisher>United States</publisher><subject>Adipose Tissue - metabolism ; Adult ; Body Composition ; Calorimetry, Indirect ; Cell Respiration ; Energy Metabolism ; Female ; HIV-1 ; HIV-Associated Lipodystrophy Syndrome - metabolism ; Humans ; Insulin Resistance ; Magnetic Resonance Spectroscopy ; Male ; Oxidation-Reduction ; Triglycerides - metabolism</subject><ispartof>American journal of physiology: endocrinology and metabolism, 2003-02, Vol.284 (2), p.E274-E280</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c418t-27b30f485a6da1c62a0489f51446621e08f984dc09e2d252786371a3fca1c4803</citedby><cites>FETCH-LOGICAL-c418t-27b30f485a6da1c62a0489f51446621e08f984dc09e2d252786371a3fca1c4803</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,3026,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12388139$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Luzi, Livio</creatorcontrib><creatorcontrib>Perseghin, Gianluca</creatorcontrib><creatorcontrib>Tambussi, Giuseppe</creatorcontrib><creatorcontrib>Meneghini, Elena</creatorcontrib><creatorcontrib>Scifo, Paola</creatorcontrib><creatorcontrib>Pagliato, Emanuela</creatorcontrib><creatorcontrib>Del Maschio, Alessandro</creatorcontrib><creatorcontrib>Testolin, Giulio</creatorcontrib><creatorcontrib>Lazzarin, Adriano</creatorcontrib><title>Intramyocellular lipid accumulation and reduced whole body lipid oxidation in HIV lipodystrophy</title><title>American journal of physiology: endocrinology and metabolism</title><addtitle>Am J Physiol Endocrinol Metab</addtitle><description>Divisions of 4  Infectious Diseases, 5  Diagnostic Radiology, and 6  Nuclear Medicine, 2  Clinical Research Unit II, and 3  Clinical Spectroscopy Unit, San Raffaele Scientific Institute, and 1  International Center for Assessment of the Nutritional Status, Universita' degli Studi di Milano, 20132 Milan, Italy Antiretroviral therapy in human immunodeficiency virus (HIV)-positive patients can induce a lipodystrophy syndrome of peripheral fat wasting and central adiposity, dyslipidemia, and insulin resistance. To test whether in this syndrome insulin resistance is associated with abnormal muscle handling of fatty acids, 12 HIV-1 patients (8 females/4 males , age = 26 ± 2 yr, HIV duratio n  = 8 ± 1 yr, body mass index = 22.0 ± 1.0 kg/m 2 , on protease inhibitors and nucleoside analog RT inhibitors) and 12 healthy subjects were studied. HIV-1 patients had a total body fat content (assessed by dual-energy X-ray absorptiometry) similar to that of controls (22 ± 1 vs. 23 ± 2%; P  = 0.56), with a topographic fat redistribution characterized by reduced fat content in the legs (18 ± 2 vs. 32 ± 3%; P  &lt; 0.01) and increased fat content in the trunk (25 ± 2 vs. 19 ± 2%; P  = 0.03). In HIV-positive patients, insulin sensitivity (assessed by QUICKI) was markedly impaired (0.341 ± 0.011 vs. 0.376 ± 0.007; P  = 0.012). HIV-positive patients also had increased total plasma cholesterol (216 ± 20   vs. 174 ± 9 mg/dl; P  = 0.05) and triglyceride (298 ± 96 vs. 87   ± 11 mg/dl; P  = 0.03) concentrations. Muscular triglyceride content assessed by means of 1 H NMR spectroscopy was higher in HIV patients in soleus [92 ±   12 vs. 42 ± 5 arbitrary units (AU); P  &lt; 0.01] and tibialis anterior (26 ± 6 vs. 11 ± 3 AU; P  = 0.04) muscles; in a stepwise regression analysis, it was strongly associated with QUICKI ( R 2  = 0.27; P  &lt; 0.0093). Even if the basal metabolic rate (assessed by indirect calorimetry) was comparable to that of normal subjects, postabsorptive lipid oxidation was significantly impaired (0.30   ± 0.07 vs. 0.88 ± 0.09 mg · kg 1 · min 1 ; P  &lt; 0.01). In conclusion, lipodystrophy in HIV-1 patients in antiretroviral treatment is associated with intramuscular fat accumulation, which may mediate the development of the insulin resistance syndrome. human immunodeficiency virus</description><subject>Adipose Tissue - metabolism</subject><subject>Adult</subject><subject>Body Composition</subject><subject>Calorimetry, Indirect</subject><subject>Cell Respiration</subject><subject>Energy Metabolism</subject><subject>Female</subject><subject>HIV-1</subject><subject>HIV-Associated Lipodystrophy Syndrome - metabolism</subject><subject>Humans</subject><subject>Insulin Resistance</subject><subject>Magnetic Resonance Spectroscopy</subject><subject>Male</subject><subject>Oxidation-Reduction</subject><subject>Triglycerides - metabolism</subject><issn>0193-1849</issn><issn>1522-1555</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkMFu3CAURVHVqpmm_YEuKq-68wQe2MCyipJmpEjZpN0iBnCGCBsXbCX--zAdR1lVXSF45149DkJfCd4S0sCFfhzdYOMWYyrJFjAm79CmDKAmTdO8RxtMJK2JYPIMfcr5EWPMGwYf0RkBKgShcoPUbpiS7pdoXAhz0KkKfvS20sbMfblPPg6VHmyVnJ2Ns9XTIQZX7aNdVjI-e3vC_FDd7H4fn8s0TymOh-Uz-tDpkN2X9TxHv66v7i9v6tu7n7vLH7e1YURMNfA9xR0TjW6tJqYFjZmQXUMYa1sgDotOCmYNlg4sNMBFSznRtDOFZgLTc_T91Dum-Gd2eVK9z8c_6cHFOSsOkgMw_l-QCN5izkgB4QSaFHNOrlNj8r1OiyJYHf2r1b_6618d_ZfQt7V93vfOvkVW4QWQJ-DgHw5PPjlVJGUfQ3xY1PUcwr17nl6bQTAF6go4U6PtSrb-d_Z1mbcMfQG64ag6</recordid><startdate>20030201</startdate><enddate>20030201</enddate><creator>Luzi, Livio</creator><creator>Perseghin, Gianluca</creator><creator>Tambussi, Giuseppe</creator><creator>Meneghini, Elena</creator><creator>Scifo, Paola</creator><creator>Pagliato, Emanuela</creator><creator>Del Maschio, Alessandro</creator><creator>Testolin, Giulio</creator><creator>Lazzarin, Adriano</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U9</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>20030201</creationdate><title>Intramyocellular lipid accumulation and reduced whole body lipid oxidation in HIV lipodystrophy</title><author>Luzi, Livio ; Perseghin, Gianluca ; Tambussi, Giuseppe ; Meneghini, Elena ; Scifo, Paola ; Pagliato, Emanuela ; Del Maschio, Alessandro ; Testolin, Giulio ; Lazzarin, Adriano</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c418t-27b30f485a6da1c62a0489f51446621e08f984dc09e2d252786371a3fca1c4803</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Adipose Tissue - metabolism</topic><topic>Adult</topic><topic>Body Composition</topic><topic>Calorimetry, Indirect</topic><topic>Cell Respiration</topic><topic>Energy Metabolism</topic><topic>Female</topic><topic>HIV-1</topic><topic>HIV-Associated Lipodystrophy Syndrome - metabolism</topic><topic>Humans</topic><topic>Insulin Resistance</topic><topic>Magnetic Resonance Spectroscopy</topic><topic>Male</topic><topic>Oxidation-Reduction</topic><topic>Triglycerides - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Luzi, Livio</creatorcontrib><creatorcontrib>Perseghin, Gianluca</creatorcontrib><creatorcontrib>Tambussi, Giuseppe</creatorcontrib><creatorcontrib>Meneghini, Elena</creatorcontrib><creatorcontrib>Scifo, Paola</creatorcontrib><creatorcontrib>Pagliato, Emanuela</creatorcontrib><creatorcontrib>Del Maschio, Alessandro</creatorcontrib><creatorcontrib>Testolin, Giulio</creatorcontrib><creatorcontrib>Lazzarin, Adriano</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of physiology: endocrinology and metabolism</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Luzi, Livio</au><au>Perseghin, Gianluca</au><au>Tambussi, Giuseppe</au><au>Meneghini, Elena</au><au>Scifo, Paola</au><au>Pagliato, Emanuela</au><au>Del Maschio, Alessandro</au><au>Testolin, Giulio</au><au>Lazzarin, Adriano</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Intramyocellular lipid accumulation and reduced whole body lipid oxidation in HIV lipodystrophy</atitle><jtitle>American journal of physiology: endocrinology and metabolism</jtitle><addtitle>Am J Physiol Endocrinol Metab</addtitle><date>2003-02-01</date><risdate>2003</risdate><volume>284</volume><issue>2</issue><spage>E274</spage><epage>E280</epage><pages>E274-E280</pages><issn>0193-1849</issn><eissn>1522-1555</eissn><abstract>Divisions of 4  Infectious Diseases, 5  Diagnostic Radiology, and 6  Nuclear Medicine, 2  Clinical Research Unit II, and 3  Clinical Spectroscopy Unit, San Raffaele Scientific Institute, and 1  International Center for Assessment of the Nutritional Status, Universita' degli Studi di Milano, 20132 Milan, Italy Antiretroviral therapy in human immunodeficiency virus (HIV)-positive patients can induce a lipodystrophy syndrome of peripheral fat wasting and central adiposity, dyslipidemia, and insulin resistance. To test whether in this syndrome insulin resistance is associated with abnormal muscle handling of fatty acids, 12 HIV-1 patients (8 females/4 males , age = 26 ± 2 yr, HIV duratio n  = 8 ± 1 yr, body mass index = 22.0 ± 1.0 kg/m 2 , on protease inhibitors and nucleoside analog RT inhibitors) and 12 healthy subjects were studied. HIV-1 patients had a total body fat content (assessed by dual-energy X-ray absorptiometry) similar to that of controls (22 ± 1 vs. 23 ± 2%; P  = 0.56), with a topographic fat redistribution characterized by reduced fat content in the legs (18 ± 2 vs. 32 ± 3%; P  &lt; 0.01) and increased fat content in the trunk (25 ± 2 vs. 19 ± 2%; P  = 0.03). In HIV-positive patients, insulin sensitivity (assessed by QUICKI) was markedly impaired (0.341 ± 0.011 vs. 0.376 ± 0.007; P  = 0.012). HIV-positive patients also had increased total plasma cholesterol (216 ± 20   vs. 174 ± 9 mg/dl; P  = 0.05) and triglyceride (298 ± 96 vs. 87   ± 11 mg/dl; P  = 0.03) concentrations. Muscular triglyceride content assessed by means of 1 H NMR spectroscopy was higher in HIV patients in soleus [92 ±   12 vs. 42 ± 5 arbitrary units (AU); P  &lt; 0.01] and tibialis anterior (26 ± 6 vs. 11 ± 3 AU; P  = 0.04) muscles; in a stepwise regression analysis, it was strongly associated with QUICKI ( R 2  = 0.27; P  &lt; 0.0093). Even if the basal metabolic rate (assessed by indirect calorimetry) was comparable to that of normal subjects, postabsorptive lipid oxidation was significantly impaired (0.30   ± 0.07 vs. 0.88 ± 0.09 mg · kg 1 · min 1 ; P  &lt; 0.01). In conclusion, lipodystrophy in HIV-1 patients in antiretroviral treatment is associated with intramuscular fat accumulation, which may mediate the development of the insulin resistance syndrome. human immunodeficiency virus</abstract><cop>United States</cop><pmid>12388139</pmid><doi>10.1152/ajpendo.00391.2001</doi></addata></record>
fulltext fulltext
identifier ISSN: 0193-1849
ispartof American journal of physiology: endocrinology and metabolism, 2003-02, Vol.284 (2), p.E274-E280
issn 0193-1849
1522-1555
language eng
recordid cdi_proquest_miscellaneous_18760741
source MEDLINE; American Physiological Society; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Adipose Tissue - metabolism
Adult
Body Composition
Calorimetry, Indirect
Cell Respiration
Energy Metabolism
Female
HIV-1
HIV-Associated Lipodystrophy Syndrome - metabolism
Humans
Insulin Resistance
Magnetic Resonance Spectroscopy
Male
Oxidation-Reduction
Triglycerides - metabolism
title Intramyocellular lipid accumulation and reduced whole body lipid oxidation in HIV lipodystrophy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T13%3A41%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Intramyocellular%20lipid%20accumulation%20and%20reduced%20whole%20body%20lipid%20oxidation%20in%20HIV%20lipodystrophy&rft.jtitle=American%20journal%20of%20physiology:%20endocrinology%20and%20metabolism&rft.au=Luzi,%20Livio&rft.date=2003-02-01&rft.volume=284&rft.issue=2&rft.spage=E274&rft.epage=E280&rft.pages=E274-E280&rft.issn=0193-1849&rft.eissn=1522-1555&rft_id=info:doi/10.1152/ajpendo.00391.2001&rft_dat=%3Cproquest_cross%3E18760741%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=18760741&rft_id=info:pmid/12388139&rfr_iscdi=true